China’s first dedicated group standard for the evaluation of tissue-extracted injectable collagen in improving skin texture and complexion has been released, filling the industry gap.

At ICIC 2026, FIMAN won multiple top awards for its outstanding innovation, premium quality and cutting-edge technology.

Mr. Chen Xinwei, Managing Director of Fiman Biotech, stood out from numerous industry elites with his outstanding leadership, robust innovation capability and remarkable social contributions.

FIMAN Wins Prestigious "China Medical Aesthetics Industry Chain Award · Leading Enterprise in Medical Aesthetic Injectables and Materials"

With outstanding performance across five key areas, it stood out and won the title of "2026 Forbes China Industry Development Leading Enterprise".

This group standard is led by FIMAN and is under the jurisdiction of the China Food and Drug Enterprise Quality and Safety Promotion Association.

“Smart Construction of Collagen, Orderly Regeneration” 2026 FIMAN “Controlled Collagen Self-Assembly Technology” Ecosystem Launch Conference was grandly held in Changchun.

Ms. Zhao Qing, Vice General Manager of FIMAN, shared her unique insights on the future development trends of collagen and her profound reflections on building a healthy and sustainable medical aesthetics industry ecosystem with industry peers.